These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 32495250)

  • 21. Gastrointestinal neuroendocrine tumors (NETs): new diagnostic and therapeutic challenges.
    Castaño JP; Sundin A; Maecke HR; Villabona C; Vazquez-Albertino R; Navarro E; Oberg K
    Cancer Metastasis Rev; 2014 Mar; 33(1):353-9. PubMed ID: 24390486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic uses of radiolabelled somatostatin receptor analogues in gastroenteropancreatic endocrine tumours.
    Gibril F; Jensen RT
    Dig Liver Dis; 2004 Feb; 36 Suppl 1():S106-20. PubMed ID: 15077919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting.
    Wild D; Béhé M; Wicki A; Storch D; Waser B; Gotthardt M; Keil B; Christofori G; Reubi JC; Mäcke HR
    J Nucl Med; 2006 Dec; 47(12):2025-33. PubMed ID: 17138746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Superior Diagnostic Performance of the GLP-1 Receptor Agonist [Lys
    Senica K; Tomazic A; Skvarca A; Kolenc Peitl P; Mikolajczak R; Hubalewska-Dydejczyk A; Lezaic L
    Mol Imaging Biol; 2020 Feb; 22(1):165-172. PubMed ID: 31098984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucagon-like peptide-1 receptor imaging for localization of insulinomas.
    Christ E; Wild D; Forrer F; Brändle M; Sahli R; Clerici T; Gloor B; Martius F; Maecke H; Reubi JC
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4398-405. PubMed ID: 19820010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neuroendocrine tumors of the gastrointestinal tract].
    Arnold C
    Praxis (Bern 1994); 2007 Jan; 96(1-2):19-28. PubMed ID: 17256557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor imaging and therapy using radiolabeled somatostatin analogues.
    de Jong M; Breeman WA; Kwekkeboom DJ; Valkema R; Krenning EP
    Acc Chem Res; 2009 Jul; 42(7):873-80. PubMed ID: 19445476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imaging tumors with peptide-based radioligands.
    Behr TM; Gotthardt M; Barth A; Béhé M
    Q J Nucl Med; 2001 Jun; 45(2):189-200. PubMed ID: 11476170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatostatin and dopamine receptor expression in neuroendocrine neoplasms: correlation of immunohistochemical findings with somatostatin receptor scintigraphy visual scores.
    Diakatou E; Alexandraki KI; Tsolakis AV; Kontogeorgos G; Chatzellis E; Leonti A; Kaltsas GA
    Clin Endocrinol (Oxf); 2015 Sep; 83(3):420-8. PubMed ID: 25808161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NEN - the role of somatostatin receptor scintigraphy in clinical setting.
    Opalińska M; Hubalewska-Dydejczyk A; Sowa-Staszczak A; Stefańska A
    Nucl Med Rev Cent East Eur; 2016; 19(2):118-25. PubMed ID: 27479789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pancreatic neuroendocrine tumours.
    Alexakis N; Neoptolemos JP
    Best Pract Res Clin Gastroenterol; 2008; 22(1):183-205. PubMed ID: 18206821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Focused dilemmas in the diagnosis and treatment of digestive system neuroendocrine neoplasms].
    Tang QY; Wang F; Liu Y
    Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(14):977-981. PubMed ID: 35399014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular Imaging and Therapy for Neuroendocrine Tumors.
    Desai H; Borges-Neto S; Wong TZ
    Curr Treat Options Oncol; 2019 Aug; 20(10):78. PubMed ID: 31468190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroendocrine Neoplasms.
    Kamboj S; Guerra-Bauman F; Mahmud H; Waheed A
    Prim Care; 2024 Sep; 51(3):549-560. PubMed ID: 39067978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of cross-sectional and molecular imaging studies in the localization of gastroenteropancreatic neuroendocrine tumors.
    Toumpanakis C; Kim MK; Rinke A; Bergestuen DS; Thirlwell C; Khan MS; Salazar R; Oberg K
    Neuroendocrinology; 2014; 99(2):63-74. PubMed ID: 24458014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pancreatic neuroendocrine tumors: contemporary diagnosis and management.
    Parbhu SK; Adler DG
    Hosp Pract (1995); 2016 Aug; 44(3):109-19. PubMed ID: 27404266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Somatostatin Receptor in Pancreatic Neuroendocrine Tumor Development, Diagnosis, and Therapy.
    Hu Y; Ye Z; Wang F; Qin Y; Xu X; Yu X; Ji S
    Front Endocrinol (Lausanne); 2021; 12():679000. PubMed ID: 34093445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours).
    Kos-Kudła B; Blicharz-Dorniak J; Strzelczyk J; Bałdys-Waligórska A; Bednarczuk T; Bolanowski M; Boratyn-Nowicka A; Borowska M; Cichocki A; Ćwikła JB; Falconi M; Foltyn W; Handkiewicz-Junak D; Hubalewska-Dydejczyk A; Jarząb B; Junik R; Kajdaniuk D; Kamiński G; Kolasińska-Ćwikła A; Kowalska A; Król R; Królicki L; Krzakowski M; Kunikowska J; Kuśnierz K; Lampe P; Lange D; Lewczuk-Myślicka A; Lewiński A; Lipiński M; Londzin-Olesik M; Marek B; Nasierowska-Guttmejer A; Nawrocki S; Nowakowska-Duława E; Pilch-Kowalczyk J; Rosiek V; Ruchała M; Siemińska L; Sowa-Staszczak A; Starzyńska T; Steinhof-Radwańska K; Sworczak K; Syrenicz A; Szawłowski A; Szczepkowski M; Wachuła E; Zajęcki W; Zemczak A; Zgliczyński W; Zieniewicz K
    Endokrynol Pol; 2017; 68(2):79-110. PubMed ID: 28597909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value of the radiolabelled GLP-1 receptor antagonist exendin(9-39) for targeting of GLP-1 receptor-expressing pancreatic tissues in mice and humans.
    Waser B; Reubi JC
    Eur J Nucl Med Mol Imaging; 2011 Jun; 38(6):1054-8. PubMed ID: 21210113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current status and future prospects of PET-imaging applications in patients with gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs).
    Papadakis GZ; Karantanas AH; Marias K; Millo C
    Eur J Radiol; 2021 Oct; 143():109932. PubMed ID: 34482177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.